[1] Practical guidance: Oral glutathione supplements: take at a consistent time each day, separated by at least two hours from meals around the dulaglutide injection day
GLP-1 related hair loss is most commonly telogen effluvium, which causes diffuse thinning across the entire scalp rather than the patterned thinning seen in androgenic alopecia (male or female pattern baldness)
The differences matter enormously
The Evidence Multiple large cardiovascular outcome trials have demonstrated GLP-1 medications reduce heart attacks, strokes, and cardiovascular death: SUSTAIN-6 (semaglutide): 26% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk
Enhancing CNS bioavailability through nanoparticle formulations, prodrug strategies, or intranasal delivery systems could improve therapeutic outcomes
This represents a quantitative reduction in GLP-1 effectiveness rather than a consistent reduction in GLP-1 levels themselves